1)間下直樹,越川克己,桐山幸三,他:空腸漿膜から管外性に発育した巨大なGISTの1例.消外30:1259-1264, 2007
2)Hirota S, Isozaki K, Moriyama Y, et al:Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
3)Miettinen M, Monihan JM, Saioma-Rikala M, et al:Gastointestinal stromal tumors/smooth muscle tumors(GIST)primary clinacopathologic and immunohistochemical study of 26 cases. Am J Surg Pathl 23:1109-1118, 1999
4)野田雅史,柳 秀憲,山村武平,他:小腸腫瘍.「消化器病診療」編集委員会(編):消化器病診療.日本消化器病学会,2004, pp 103-107
5)八尾恒良,八尾建史,真武弘明,他:小腸腫瘍―最近5年間(1995~1999)の本邦報告例の集計.胃と腸36:871-881, 2001
6)Emory TS, Sobin LH, Lukes L, et al:Prognosis of gastrointestinal smooth muscle(stromal)tumors. Am J Surg Pathol 23:82-87, 1999
7)岩下明徳,大重要人,原岡誠司,他:gastrointestinal stromal tumor(GIST)の臨床病理.胃と腸36:1113-1127, 2001
Rosai J (ed):Ackerman's Surgical Pathology. 8th ed. St Louis, Mosby, 1996, pp 645-647
9)Goldblum JR, Appelman HD:Stromal tumor of the duodenum. A histlogic and immunohistochemical study of 20 cases. Am J Surg Pathol 19:71-80, 1995
10)西田俊朗,大森 健,松田 暉:Gastrointestinal Stromal Tumor.癌と化療31:331-336, 2004
11)Miettinen M, Lasota J:Gastrointestinal stromal tumors:pathology and prognosis at different sites. Semin Diagn Pathol 23:70-83, 2006
12)藤田淳也,島野高志,福島幸男,他:小腸GISTの診断と治療.外科63:1062-1069, 2001
13)Crosby JA, Catton CN, Davis A, et al:Malignant gastrointestinal stromal tumors of the small intestine:a review of 50 cases from a prospective database. Ann Surg Oncol 8:50-59, 2001
14)Brainard JA, Goldblum JR:Stromal tumors of the jejunum and ileum:a clinicopathologic study of 39 cases. Am J Surg Pathol 21:407-416, 1997
15)Miettinen M, Sobin LH, Lasota J:Gastrointestinal stromal tumors of the stomach:a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52-68, 2005
16)Joensuu H, Eriksson M, Hatrmann J, et al:Twelve versus 36 months of adjuvant imatinib(IM)as treatment of operable GIST with a high risk of recurrence:final results of a randomized trial(SSGⅩⅧ/AIO). 47th Annual Meeting of the American Society of Clinical Oncology. Abstract No. LBA1, June 5, 2011